A phase I dose escalation study of edotecarin (PHA-782615) and cisplatin in adult patients with advanced/metastatic solid tumors
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Edotecarin (Primary) ; Cisplatin
- Indications Gastric cancer; Oesophageal cancer; Solid tumours
- Focus Adverse reactions
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2005 New trial record.